期刊
NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 37, 期 11, 页码 2234-2240出版社
OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfac181
关键词
hemodialysis; potassium; renal urea clearance; residual kidney function
资金
- Institute for Clinical and Translational Science of the National Institutes of Health [T35DK128788]
This study found that hyperkalemia is associated with a decline in residual kidney function among hemodialysis patients. These findings may have important clinical implications in the management of hyperkalemia in advanced CKD if confirmed in additional clinical trials.
Background Hyperkalemia is associated with kidney function decline in patients with non-dialysis dependent chronic kidney disease, but this relationship is unclear for residual kidney function (RKF) among hemodialysis (HD) patients. Methods We conducted a retrospective cohort study of 6655 patients, who started HD January 2007 and December 2011 and who had data on renal urea clearance (KRU). Serum potassium levels were stratified into four groups (i.e. <= 4.0, >4.0 to <= 4.5, >4.5 to <= 5.0 and >5.0 mEq/L) and 1-year KRU slope for each group was estimated by a linear mixed-effects model. Results Higher serum potassium was associated with a greater decline in KRU, and the greatest decrease in KRU (-0.20, 95% confidence interval -0.50 to -0.06) was observed for baseline potassium >5.0 mEq/L in the fully adjusted model. Mediation analysis showed that KRU slope mediated 1.78% of the association between serum potassium and mortality. Conclusions Hyperkalemia is associated with a decline in RKF amongst incident HD patients. These findings may have important clinical implications in the management of hyperkalemia in advanced CKD if confirmed in additional clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据